| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 134,866 | 133,337 | 136,323 | | Cost of Revenue | 95,319 | 96,117 | 115,040 | | | Gross Profit | 39,547 | 37,220 | 21,283 | | | Operating Expenses | | Research Development | 1,993 | 1,267 | 1,457 | | Selling General and Administrative | 24,721 | 23,202 | 22,301 | | Non Recurring | 2,191 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 10,642 | 12,751 | (2,475) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19 | 66 | 83 | | Earnings Before Interest And Taxes | 10,661 | 12,817 | (2,392) | | Interest Expense | 4,215 | 5,514 | 5,996 | | Income Before Tax | 6,446 | 7,303 | (8,388) | | Income Tax Expense | 2,589 | 2,696 | (3,432) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,857 | 4,607 | (4,956) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,857 | 4,607 | (4,956) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,857 | $4,607 | ($4,956) |
|
1.52% Nasdaq 0.00%
Income Statement
